Does Angelman Syndrome Come From the Maternal or Paternal Gene?

Angelman syndrome traces to the mother’s side of one gene. A child develops it when the copy inherited from the mother doesn’t work in the brain.1Nature Education. Imprinting and Genetic Disease: Angelman, Prader-Willi and Beckwith-Weidemann Syndromes That doesn’t mean the mother did anything wrong or carried a fault herself; in most families it happens by chance. The odd part is that the father’s copy of the same gene is perfectly normal, yet the brain keeps it switched off, which also makes it a target for new treatments.2eLife. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome

Why Only the Mother’s Copy Matters in the Brain

Everyone inherits two copies of most genes, one from each parent, and usually both work. UBE3A, the gene behind Angelman syndrome, is different. It works from both copies in most of the body, yet only from the mother’s copy in nearly all brain cells.3PubMed Central. Angelman Syndrome: Insights into Genomic Imprinting and Neurodevelopmental Phenotypes

The reason is imprinting, a process in which a gene’s activity depends on which parent it came from.4PubMed Central. A bipartite boundary element restricts UBE3A imprinting to mature neurons In mature nerve cells, the father’s UBE3A copy is switched off. The switch is a long stretch of genetic message, read off the father’s chromosome, that blocks his UBE3A copy from being used.5bioRxiv. Antisense oligonucleotides targeting UBE3A-ATS restore expression of UBE3A by relieving transcriptional interference So if the mother’s copy is missing or broken, the brain has no working UBE3A, because the father’s copy can’t fill in.6Nature Education. Imprinting and Genetic Disease: Angelman, Prader-Willi and Beckwith-Weidemann Syndromes

Unlike in many inherited conditions, no healthy second copy covers for a faulty one here, because the father’s copy is deliberately off. A single missing or faulty maternal copy is enough.

The switching off is specific to nerve cells and to timing. Early in development the father’s copy is still active in nerve cells, and the silencing comes on as the brain matures, which helps explain why signs emerge over the first year rather than at birth. Because the rest of the body uses both copies, losing the mother’s copy doesn’t damage most organs, and Angelman syndrome is mainly a condition of the nervous system.

The UBE3A gene makes a protein that tags other proteins for removal, helping keep the connections between nerve cells in balance.7PubMed Central. The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions The same stretch of chromosome 15 is linked to Prader-Willi syndrome, which happens when the father’s contribution is lost instead.8Nature Education. Imprinting and Genetic Disease: Angelman, Prader-Willi and Beckwith-Weidemann Syndromes One chromosome region can therefore produce two quite different conditions, depending on which parent’s copy is missing.

The Four Ways the Mother’s Copy Can Be Lost

Each type means something different for what went wrong. With a deletion, the mother’s copy is physically absent, along with neighbouring genes, so nothing is left to repair or switch on from that chromosome. With a UBE3A change, the gene is there and in the right place, but its wording is altered so the protein can’t do its job. With a faulty on/off mark, the wording can be entirely normal; the label is what’s wrong, telling the cell to treat the mother’s copy like the father’s.

With two copies from the father, both UBE3A copies are silenced in the brain, so the effect matches losing the mother’s copy.13PubMed. Maternal but not paternal transmission of 15q11-13-linked nondeletion Angelman syndrome leads to phenotypic expression Nothing in either copy is broken; both simply come from the parent whose copy is switched off in the brain. This usually follows a chance error when the egg or early embryo divides its chromosomes.

In a small share of people, no genetic cause is found even though the signs fit. The diagnosis then rests on the clinical picture together with further genetic work, and a cause may still sit in a part of the gene or its controls that routine tests miss. Rarely, only some cells carry the change, which can mean milder signs, such as some spoken language in one reported case.14PubMed Central. Atypical presentation of Angelman syndrome with intact expressive language due to low‐level mosaicism

Could Angelman Syndrome Happen Again in Another Child

More than 98% of deletions happen by a random event and are not inherited, leaving a repeat risk well under 1%.15University of Florida College of Medicine. Angelman Syndrome and Genetic Counseling The other 1–2% come from a rearrangement in the mother’s chromosome 15, such as a balanced swap of chromosome pieces, which raises the risk.16University of Florida College of Medicine. Angelman Syndrome and Genetic Counseling Two copies from the father, when neither parent has a chromosome rearrangement, likewise carry under a 1% repeat risk.17American Journal of Medical Genetics. Genetic counseling in Angelman syndrome: The challenges of multiple causes

When no deletion or two father’s copies is found, the repeat risk can be as high as 50%.18American Journal of Medical Genetics. Genetic counseling in Angelman syndrome: The challenges of multiple causes That’s because a UBE3A change or an on/off-switch fault may be carried silently by the mother.19American Journal of Medical Genetics. Genetic counseling in Angelman syndrome: The challenges of multiple causes A change on the copy a woman inherited from her own father sits on a copy that is switched off in her brain anyway, so she has no symptoms. The same change on the copy from her own mother would have affected her, which is why carriers are usually women who got it from their father. Each of her children has a chance of receiving the changed copy, and a child who receives it from her is affected. That’s where the figure of up to 50% comes from. Up to 50% is a ceiling that applies when the mother carries the change; if testing shows she doesn’t, the risk falls back to a small chance of a new change.

Parents considering another pregnancy should ask for testing of the mother and sometimes extended family. A genetic counseling visit starts with the child’s exact type from the report. The counselor may offer chromosome or gene tests to one or both parents, and the results give a family-specific risk rather than a general figure. Options in a later pregnancy can include prenatal or embryo testing.

Does the Genetic Type Change How a Child Is Affected

All children with Angelman syndrome have developmental delay noticeable by 6–12 months, very limited speech, unsteady walking, shaky limbs, and a happy, excitable manner with short attention.20PubMed. Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms Seizures, a small head size, and curving of the spine occur in more than 80%.21PubMed. Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms In infancy the signs are vague, and the recognizable pattern often appears only later in childhood.22PubMed. Neurological aspects of the Angelman syndrome

On average, children with a deletion are the most affected, while two father’s copies and faulty on/off marks are the mildest.23PubMed Central. Distinct phenotypes distinguish the molecular classes of Angelman syndrome Compared with two father’s copies, deletions brought swallowing problems in about 74% versus 22%, and floppy muscles in 73% versus 29%.24PubMed. Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects Children with two father’s copies tended to grow better, have fewer seizures, and show stronger thinking skills.25PubMed. Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects Children with a UBE3A gene change tended to gain skills faster than those with deletions.26PubMed Central. Developmental Skills of Individuals with Angelman Syndrome Assessed Using the Bayley-III These are group averages, so an individual child can differ; a child with a deletion can do better than a child with two father’s copies.

A deletion removes several neighbouring genes along with UBE3A, and losing those extra genes adds to the effects. Other types affect UBE3A without removing nearby genes.

Knowing the type helps doctors anticipate seizure and feeding needs, but it shouldn’t set limits on therapy goals. Early speech, movement, and communication therapies benefit all types.

How Doctors Test for Angelman Syndrome

The usual first test is a methylation test, which checks the chemical on/off marks on chromosome 15 to see whether a working mother’s pattern is present.27PubMed Central. Angelman Syndrome Genetic Testing It needs only a blood sample. An abnormal result confirms a deletion, two father’s copies, or a faulty on/off mark, and further tests then sort out which.28PubMed Central. Angelman Syndrome Genetic Testing Follow-on tests such as a chromosome microarray and parental DNA comparison identify the type.

A normal result doesn’t rule Angelman syndrome out, because UBE3A gene changes leave the marks normal, so gene sequencing comes next.29PubMed Central. Angelman Syndrome Genetic Testing Sequencing reads the gene’s wording and can find a change the marks can’t show. If it is also normal, doctors may check for a missing or duplicated stretch inside the gene and consider other conditions with similar signs, since several can look alike. A very small proportion of cells with the change can make results subtle, as in one child whose test showed about 10% affected cells.30PubMed Central. Atypical presentation of Angelman syndrome with intact expressive language due to low‐level mosaicism

The precise type matters beyond diagnosis. It decides the family’s repeat risk, may affect eligibility for clinical trials, and guides which relatives are offered testing.

Treatments Aiming to Switch On the Father’s Copy

Every child already has a healthy copy from the father, so the task is only to lift a natural switch-off. A leading strategy is to block the message that silences it.31eLife. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome

The father’s chromosome makes a long message that blocks his own UBE3A copy, so treatment targets that message rather than the gene. Short engineered strands of genetic material bind to it and lead to its breakdown, which can reactivate the father’s copy in human nerve cells grown in a lab.32PubMed. An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript The brain can then make the UBE3A protein these children lack. In mice, this approach restored disturbed brain rhythms and sleep, in both young and adult animals.33eLife. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome One such drug, rugonersen, has been tested in children with Angelman syndrome in an early safety trial.34PubMed. The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trial

These drugs wear off and need repeated injections into the spinal fluid, a burden for a lifelong condition.35PubMed Central. Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA So researchers are testing one-time gene editing to silence the blocker permanently, so far in animals.36PubMed Central. Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA Some small-molecule drugs can also switch on the father’s copy in mouse nerve cells, though earlier ones posed safety challenges.37PubMed Central. Ube3a unsilencer for the potential treatment of Angelman syndrome

Early trials test safety and dosing, not proven benefit, and no reactivation treatment is yet approved for routine use. Families can register with patient groups and trial databases, and knowing the child’s exact type helps with eligibility.

The approach needs an intact father’s copy, which every genetic type has. Children with two copies from the father have two intact but switched-off copies, so in principle reactivation could help them too.